779 related articles for article (PubMed ID: 15520109)
1. Neurodevelopmental outcome and growth at 18 to 22 months' corrected age in extremely low birth weight infants treated with early erythropoietin and iron.
Ohls RK; Ehrenkranz RA; Das A; Dusick AM; Yolton K; Romano E; Delaney-Black V; Papile LA; Simon NP; Steichen JJ; Lee KG;
Pediatrics; 2004 Nov; 114(5):1287-91. PubMed ID: 15520109
[TBL] [Abstract][Full Text] [Related]
2. Erythropoietin concentrations and neurodevelopmental outcome in preterm infants.
Bierer R; Peceny MC; Hartenberger CH; Ohls RK
Pediatrics; 2006 Sep; 118(3):e635-40. PubMed ID: 16908620
[TBL] [Abstract][Full Text] [Related]
3. Beneficial effects of breast milk in the neonatal intensive care unit on the developmental outcome of extremely low birth weight infants at 18 months of age.
Vohr BR; Poindexter BB; Dusick AM; McKinley LT; Wright LL; Langer JC; Poole WK;
Pediatrics; 2006 Jul; 118(1):e115-23. PubMed ID: 16818526
[TBL] [Abstract][Full Text] [Related]
4. Neurodevelopmental and growth outcomes of extremely low birth weight infants after necrotizing enterocolitis.
Hintz SR; Kendrick DE; Stoll BJ; Vohr BR; Fanaroff AA; Donovan EF; Poole WK; Blakely ML; Wright L; Higgins R;
Pediatrics; 2005 Mar; 115(3):696-703. PubMed ID: 15741374
[TBL] [Abstract][Full Text] [Related]
5. Changes in neurodevelopmental outcomes at 18 to 22 months' corrected age among infants of less than 25 weeks' gestational age born in 1993-1999.
Hintz SR; Kendrick DE; Vohr BR; Poole WK; Higgins RD;
Pediatrics; 2005 Jun; 115(6):1645-51. PubMed ID: 15930228
[TBL] [Abstract][Full Text] [Related]
6. Major congenital anomalies place extremely low birth weight infants at higher risk for poor growth and developmental outcomes.
Walden RV; Taylor SC; Hansen NI; Poole WK; Stoll BJ; Abuelo D; Vohr BR;
Pediatrics; 2007 Dec; 120(6):e1512-9. PubMed ID: 17984212
[TBL] [Abstract][Full Text] [Related]
7. Growth, efficacy, and safety of feeding an iron-fortified human milk fortifier.
Berseth CL; Van Aerde JE; Gross S; Stolz SI; Harris CL; Hansen JW
Pediatrics; 2004 Dec; 114(6):e699-706. PubMed ID: 15545616
[TBL] [Abstract][Full Text] [Related]
8. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months.
Ambalavanan N; Tyson JE; Kennedy KA; Hansen NI; Vohr BR; Wright LL; Carlo WA;
Pediatrics; 2005 Mar; 115(3):e249-54. PubMed ID: 15713907
[TBL] [Abstract][Full Text] [Related]
9. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia.
Ehrenkranz RA; Walsh MC; Vohr BR; Jobe AH; Wright LL; Fanaroff AA; Wrage LA; Poole K;
Pediatrics; 2005 Dec; 116(6):1353-60. PubMed ID: 16322158
[TBL] [Abstract][Full Text] [Related]
10. Persistent beneficial effects of breast milk ingested in the neonatal intensive care unit on outcomes of extremely low birth weight infants at 30 months of age.
Vohr BR; Poindexter BB; Dusick AM; McKinley LT; Higgins RD; Langer JC; Poole WK;
Pediatrics; 2007 Oct; 120(4):e953-9. PubMed ID: 17908750
[TBL] [Abstract][Full Text] [Related]
11. Neurodevelopmental outcome of extremely low birth weight infants randomly assigned to restrictive or liberal hemoglobin thresholds for blood transfusion.
Whyte RK; Kirpalani H; Asztalos EV; Andersen C; Blajchman M; Heddle N; LaCorte M; Robertson CM; Clarke MC; Vincer MJ; Doyle LW; Roberts RS;
Pediatrics; 2009 Jan; 123(1):207-13. PubMed ID: 19117884
[TBL] [Abstract][Full Text] [Related]
12. [Usefulness of erythropoietin in the treatment of anemia of prematurity. Influence of birth weight].
Carbonell Estrany X; Figueras Aloy J; Pérez Fernández JM; Fernández López A; González Luis G; Salvía Roiges MD
An Esp Pediatr; 1999 Sep; 51(3):281-6. PubMed ID: 10575752
[TBL] [Abstract][Full Text] [Related]
13. Higher cumulative doses of erythropoietin and developmental outcomes in preterm infants.
Brown MS; Eichorst D; Lala-Black B; Gonzalez R
Pediatrics; 2009 Oct; 124(4):e681-7. PubMed ID: 19786428
[TBL] [Abstract][Full Text] [Related]
14. An approach to using recombinant erythropoietin for neuroprotection in very preterm infants.
Fauchère JC; Dame C; Vonthein R; Koller B; Arri S; Wolf M; Bucher HU
Pediatrics; 2008 Aug; 122(2):375-82. PubMed ID: 18676556
[TBL] [Abstract][Full Text] [Related]
15. Neurodevelopmental and growth outcomes of extremely low birth weight infants who are transferred from neonatal intensive care units to level I or II nurseries.
Lainwala S; Perritt R; Poole K; Vohr B;
Pediatrics; 2007 May; 119(5):e1079-87. PubMed ID: 17403821
[TBL] [Abstract][Full Text] [Related]
16. Intrauterine, early neonatal, and postdischarge growth and neurodevelopmental outcome at 5.4 years in extremely preterm infants after intensive neonatal nutritional support.
Franz AR; Pohlandt F; Bode H; Mihatsch WA; Sander S; Kron M; Steinmacher J
Pediatrics; 2009 Jan; 123(1):e101-9. PubMed ID: 19117831
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietin and prematurity--where do we stand?
Carbonell-Estrany X; Figueras-Aloy J; Alvarez E
J Perinat Med; 2005; 33(4):277-86. PubMed ID: 16207112
[TBL] [Abstract][Full Text] [Related]
18. Neurodevelopmental outcomes of extremely low birth weight infants <32 weeks' gestation between 1993 and 1998.
Vohr BR; Wright LL; Poole WK; McDonald SA
Pediatrics; 2005 Sep; 116(3):635-43. PubMed ID: 16143580
[TBL] [Abstract][Full Text] [Related]
19. Poor predictive validity of the Bayley Scales of Infant Development for cognitive function of extremely low birth weight children at school age.
Hack M; Taylor HG; Drotar D; Schluchter M; Cartar L; Wilson-Costello D; Klein N; Friedman H; Mercuri-Minich N; Morrow M
Pediatrics; 2005 Aug; 116(2):333-41. PubMed ID: 16061586
[TBL] [Abstract][Full Text] [Related]
20. One-year follow-up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomized, controlled trials.
Moya F; Sinha S; Gadzinowski J; D'Agostino R; Segal R; Guardia C; Mazela J; Liu G;
Pediatrics; 2007 Jun; 119(6):e1361-70. PubMed ID: 17533176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
